Does endotoxin-activated complement alter myocellular sodium homeostasis during sepsis?
暂无分享,去创建一个
[1] R. Barrington,et al. The role of complement in inflammation and adaptive immunity , 2001, Immunological reviews.
[2] D. Jacobs,et al. In vitro complement activation favoring soluble C5b-9 complex formation alters myocellular sodium homeostasis. , 2001, Surgery.
[3] V. M. Holers,et al. Complement is activated in kidney by endotoxin but does not cause the ensuing acute renal failure. , 2000, Kidney international.
[4] I. Chaudry,et al. Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin , 2000, Critical care medicine.
[5] D. Jacobs,et al. Sublytic complement attack increases intracellular sodium in rat skeletal muscle. , 2000, The Journal of surgical research.
[6] Z. Fishelson,et al. Cell desensitization by sublytic C5b‐9 complexes and calcium ionophores depends on activation of protein kinase C , 2000, European journal of immunology.
[7] B. Holzmann,et al. Endotoxin-Induced Lung Inflammation Is Independent of the Complement Membrane Attack Complex , 2000, Infection and Immunity.
[8] T. Ninomiya,et al. Sodium overload through voltage-dependent Na+ channels induces necrosis and apoptosis of rat superior cervical ganglion cells in vitro , 2000, Brain Research Bulletin.
[9] L. Larsson,et al. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: Mechanisms at the cellular and molecular levels , 2000, Critical care medicine.
[10] E. Hund. Myopathy in critically ill patients. , 1999, Critical care medicine.
[11] H. Rus,et al. Complement activation and atherosclerosis. , 1999, Molecular immunology.
[12] Z. Fishelson,et al. Complement resistance of tumor cells: basal and induced mechanisms. , 1999, Molecular immunology.
[13] S. V. Kotelevtsev,et al. Inversion of the Intracellular Na+/K+Ratio Blocks Apoptosis in Vascular Smooth Muscle at a Site Upstream of Caspase-3* , 1999, The Journal of Biological Chemistry.
[14] Jianzhu Chen,et al. A Critical Role of Natural Immunoglobulin M in Immediate Defense Against Systemic Bacterial Infection , 1998, The Journal of experimental medicine.
[15] M. Ferretti,et al. Heterotrimeric G proteins physically associated with the lipopolysaccharide receptor CD14 modulate both in vivo and in vitro responses to lipopolysaccharide. , 1998, The Journal of clinical investigation.
[16] Schlag,et al. Anti‐TNF Treatment of Baboons with Sepsis Reduces TNF‐α, IL‐6 and IL‐8, but not the Degree of Complement Activation , 1998, Scandinavian journal of immunology.
[17] W. Hop,et al. Complement Activation in Relation to Capillary Leakage in Children with Septic Shock and Purpura , 1998, Infection and Immunity.
[18] P. Póvoa,et al. C-reactive protein as an indicator of sepsis , 1998, Intensive Care Medicine.
[19] J. Papillon,et al. Complement activates phospholipases and protein kinases in glomerular epithelial cells. , 1998, Kidney international.
[20] C. Hack,et al. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. , 1998, Journal of immunology.
[21] C. Bortner,et al. A Primary Role for K+ and Na+ Efflux in the Activation of Apoptosis* , 1997, The Journal of Biological Chemistry.
[22] T. Badea,et al. Sublytic Terminal Complement Attack on Myotubes Decreases the Expression of mRNAs Encoding Muscle‐Specific Proteins , 1997, Journal of neurochemistry.
[23] P. Gasque,et al. Human skeletal myoblasts spontaneously activate allogeneic complement but are resistant to killing. , 1996, Journal of immunology.
[24] M. Rich,et al. Muscle is electrically inexcitable in acute quadriplegic myopathy , 1996, Neurology.
[25] E. Gelfand,et al. Ouabain induces inhibition of the progression phase in human T‐cell proliferation , 1995, Journal of cellular physiology.
[26] S. Greenberg,et al. Soluble Ligands of the αvβ4 Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[27] H. Lassmann,et al. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. , 1994, Journal of immunology.
[28] C. Hack,et al. Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern , 1993, Infection and immunity.
[29] R. Latimer,et al. Endotoxin‐induced organ injury , 1993, Critical care medicine.
[30] M. Everts,et al. Activation of the Na-K pump by intracellular Na in rat slow- and fast-twitch muscle. , 1992, Acta physiologica Scandinavica.
[31] B. Lucchesi,et al. Effects of complement activation in the isolated heart. Role of the terminal complement components. , 1992, Circulation research.
[32] C. Dinarello,et al. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. , 1991, The Journal of clinical investigation.
[33] C. Natanson,et al. Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. , 1990, Chest.
[34] T. Hugli,et al. Endotoxin-induced shock in the rat. A role for C5a. , 1989, The American journal of pathology.
[35] C. Natanson,et al. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. , 1989, The Journal of clinical investigation.
[36] P. Little,et al. The effects of alterations in membrane sodium transport on rat aortic smooth muscle proliferation , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[37] D. Tosteson,et al. Complement induces a transient increase in membrane permeability in unlysed erythrocytes. , 1988, The Journal of clinical investigation.
[38] J. Tomás,et al. Role of lipopolysaccharide and complement in susceptibility of Escherichia coli and Salmonella typhimurium to non-immune serum. , 1988, Journal of general microbiology.
[39] T. Mollnes,et al. Terminal complement complexes and anaphylatoxins in septic and ischemic patients. , 1988, Archives of surgery.
[40] B. Warner,et al. Reduced muscle amino acid uptake in sepsis and the effects in vitro of septic plasma and interleukin-1. , 1986, Surgery.
[41] T. Raffin,et al. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. , 1986, The Journal of clinical investigation.
[42] L. Kline,et al. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). , 1977, Journal of immunology.
[43] Morgan Bp. Regulation of the complement membrane attack pathway. , 1999 .
[44] C. Hack,et al. Complement activation in patients with sepsis is in part mediated by C-reactive protein. , 1998, The Journal of infectious diseases.
[45] J. Bhattacharya,et al. Soluble complex of complement increases hydraulic conductivity in single microvessels of rat lung. , 1993, The Journal of clinical investigation.
[46] J. Halperin,et al. Membrane signaling by complement C5b-9, the membrane attack complex , 1993, Immunologic research.
[47] M. Rynkiewicz,et al. Transient changes in erythrocyte membrane permeability are induced by sublytic amounts of the complement membrane attack complex (C5b-9). , 1993, Blood.
[48] G. Shires,et al. Assessment of the early cellular membrane response to live Escherichia coli bacteremia. , 1989, The Journal of surgical research.
[49] C. Hack,et al. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. , 1989, The American journal of medicine.
[50] M. Shin,et al. Cytotoxic Action and Other Metabolic Consequences of Terminal Complement Proteins , 1988 .